![]() |
|
|
Vol. 285, Issue 3, 1255-1259, June 1998
Departments of Internal Medicine and Pharmacological and
Physiological Science, Saint Louis University School of Medicine, St.
Louis. Missouri
Administration of exogenous sulfidopeptide leukotrienes (LTs) is
associated with enhanced microvascular permeability. In addition, endogenous LTs have been implicated as participants in permeability (nonhydrostatic) edema formation. The source of LTs for interaction with the microvasculature is, however, unknown. We hypothesized that
pericytes contribute to vascular LT synthesis. Under basal conditions
and after incubation with either the calcium ionophore, A23187 (0-1 µM), or arachidonic acid (20 µM), bovine retinal pericytes (BRPs)
did not produce significant amounts of sulfidopeptide LTs. In contrast,
in the presence of polymorphonuclear leukocytes (PMNs), which can
synthesize LTA4, but not sulfidopeptide leukotrienes, incubation of BRPs with A23187 resulted in dose-dependent increases in
LTC4/D4/E4 production (peak:
35.4 ± 5 pg/µg protein; n = 12). Similarly,
BRPs, incubated with exogenous, authentic LTA4 (10 µM),
synthesized sulfidopeptide LTs (peak: 18.9 ± 5 pg/µg protein, n = 3). Preincubation (30 min) of BRPs with PMNs
and the lipoxygenase inhibitor, esculetin (1 × 10
4 M; n = 12), reduced
peak A23187-induced production of LTs by 63.9 ± 7%. Finally,
Northern blot analysis revealed mRNA for 5-lipoxygenase to be present
in human and bovine PMNs, but not in BRPs. These results suggest that
pericytes produce sulfidopeptide LTs only when provided with
LTA4 from an external source such as the PMN. Interactions
between pericytes and PMNs may lead to the production of sulfidopeptide
LTs, which, in turn, could alter microvascular permeability.
This article has been cited by other articles:
![]() |
K. Tokita, Y. Uchida, and T. Yamamoto Roles of leukocytosis and cysteinyl leukotriene in polymorphonuclear leukocyte-dependent plasma extravasation J. Leukoc. Biol., December 1, 2006; 80(6): 1308 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kociok, A. Hueber, P. Esser, U. Schraermeyer, G. Thumann, T. T. Luther, J. Jordan, G. Welsandt, and B. Kirchhof Vitreous Treatment of Cultured Human RPE Cells Results in Differential Expression of 10 New Genes Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2474 - 2480. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hardy, I. Dumont, M. Bhattacharya, X. Hou, P. Lachapelle, D. R. Varma, and S. Chemtob Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy Cardiovasc Res, August 18, 2000; 47(3): 489 - 509. [Abstract] [Full Text] [PDF] |
||||